High-dose treosulfan in conditioning prior to hematopoietic stem cell transplantation

By Główka Franciszek K   Romański Michał   Wachowiak Jacek  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 10, 2010-10 ,pp. : 1275-1295

Informa Healthcare

Access to resources Recommend Favorite

Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma

By Chen Yi-Bin   Batchelor Tracy   Li Shuli   Hochberg Ephraim   Brezina Mark   Jones Sooae   Del Rio Candice   Curtis Morgan   Ballen Karen K.   Barnes Jeffrey   Chi Andrew S.   Dietrich Jorg   Driscoll Jessica   Gertsner Elizabeth R.   Hochberg Fred   LaCasce Ann S.   McAfee Steven L.   Spitzer Thomas R.   Nayak Lakshmi   Armand Philippe  

Cancer, Vol. 121, Iss. 2, 2015-01 ,pp. : 226-233

Blackwell Publishing

Access to resources Recommend Favorite

High-dose cyclophosphamide plus autologous stem-cell transplantation is effective in severe, refractory autoimmune disorders

By  

Inpharma, Vol. 1, Iss. 1536, 2006-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Chemo + autologous stem cell transplantation an asset in RA

By  

Inpharma, Vol. 1, Iss. 1508, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Chemo + autologous stem cell transplantation an asset in RA

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 488, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite